About Mark Murcko
Mark Murcko is a director at Relay Therapeutics.
Form D filings name Mark Murcko as a board director at Myris Therapeutics.
Mark Murcko reports to the SEC as a director of 1 public company.
Mark Murcko first appears on SEC filings in 2020.
Experience
This experience comes from Mark Murcko's profile and from SEC filings. For roles taken from filings, the years are when the filings name Mark Murcko in the role, so the role may have started earlier or lasted longer.
ES
Excelsior Sciences Current
SAB member and Board Observer
2024 – Present
BS
BioHybrid Solutions Current
Member of the Board of Directors
2022 – Present
OC
Octant Current
Strategic Advisor and Board member
2020 – Present
MS
Museum of Science Current
Museum Advisor
2019 – Present
DT
Dewpoint Therapeutics Current
Member of the Board of Directors
2018 – Present
RI
Relay Therapeutics, Inc. Current
Founder & Member of the Board of Directors
2016 – Present · Public company (RLAY)
MI
MIT Current
Senior Lecturer, Dep't of Biological Engineering
2012 – Present
DL
Disruptive Biomedical, LLC Current
Principal
2011 – Present
AP
Astex Pharmaceuticals Current
SAB member
2011 – Present
Myris Therapeutics, Inc.
Board Director
2026 · Sharpsburg, PA
Develops antibody-linked medicines for people with cancer.
HI
HIBio
Member of the Board of Directors
2021 – 2024
RP
RADD Pharmaceuticals
Member of the Board of Directors
2020 – 2024
GC
Gordon Research Conferences
Member Board of Trustees
2016 – 2024
SY
Symeres
Strategic Advisor
2015 – 2024
TI
Tri-Institutional Therapeutics Discovery Institute, Inc.
Chair, SAB
2014 – 2024
SB
SQZ Biotech
Member, SAB and Board of Directors
2015 – 2020
NU
NuMedii
Chair, SAB
2014 – 2019
AT
Arvinas Therapeutics
SAB member
2013 – 2019
MT
Morphic Therapeutic
Board Member and Chair, SAB
2015 – 2018
NP
Navitor Pharmaceuticals
SAB Member
2014 – 2018
SP
Syros Pharmaceuticals
Founding Advisor & SAB member
2013 – 2018
Key Colleagues at Startups
The people Mark Murcko works with at each company, as listed on that company's latest Form D.
Myris Therapeutics, Inc. · Form D, Oct 14, 2026
Laura Benjamin
CEO, Board Director
RW
Rebecca Wolfe
Executive officer
AS
Antonina Simakova
Executive officer
Alan Russell
Promoter
David Colaizzi
Board Chairman
BF
Barbara Fox
Board Director
Krzysztof Matyjaszewski
Co-Founder and Board Director